Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.
about
Artesunate versus quinine for treating severe malariaReview of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationA Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal CancerArtemether for severe malariaArtesunate versus quinine for treating severe malariaArtesunate versus quinine for treating severe malariaArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialSevere falciparum malaria in Gabonese children: clinical and laboratory featuresAssessment of volume depletion in children with malariaPharmacokinetic and pharmacodynamic considerations in antimalarial dose optimizationArtemisinins: their growing importance in medicinePopulation pharmacokinetics of artesunate and dihydroartemisinin following intra-rectal dosing of artesunate in malaria patientsIntramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled TrialHealth worker perspectives on the possible use of intramuscular artesunate for the treatment of severe malaria at lower-level health facilities in settings with poor access to referral facilities in Nigeria: a qualitative study.Population pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria.Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria.Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Management of severe paediatric malaria in resource-limited settings.Artemisinins.Antimalarial activity of Garcinia mangostana L rind and its synergistic effect with artemisinin in vitro.Research priorities in the management of severe Plasmodium falciparum malaria in children.Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.Effects of body size and gender on the population pharmacokinetics of artesunate and its active metabolite dihydroartemisinin in pediatric malaria patients.Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.Toxicity of the antimalarial artemisinin and its dervatives.Pharmacokinetic profile of artemisinin derivatives and companion drugs used in artemisinin-based combination therapies for the treatment of Plasmodium falciparum malaria in children.Prediction of Antimalarial Drug Clearance in Children: A Comparison of Three Different Interspecies Scaling Methods.In vitro activity and interaction of clindamycin combined with dihydroartemisinin against Plasmodium falciparum.Pharmacodynamics of antimalarial chemotherapy.
P2860
Q21032520-024B0BA1-0F64-4B05-A5C4-B1CAC75AE91DQ21034080-3CB8A0B3-A2B6-40B0-BA62-B6595C1EAB37Q22061945-695373CF-2D82-468A-8700-F9D881F371DBQ24193663-21E2168A-B47E-446F-AEC5-3825E9FD2E41Q24235937-4F974EFA-719B-4B35-B9F6-B847AB7A4967Q24242928-88AA001B-A16D-4E46-9E1F-D37FF7A2B317Q24630683-78C068D7-847B-448D-8253-6FF15402BD1DQ24795463-72C58445-16CE-45DA-A054-4C48C1681882Q24802309-1A66F6F7-2379-4B7E-88A6-0A54927960A1Q26830528-D77D5B1C-65DE-458F-8968-47029B6BB1C7Q27489880-E1B7D406-2E03-4D89-BB84-63A01738A740Q28469076-D4446D68-4D03-479D-BAA8-944D3606EF06Q28552379-764F777C-1E3D-4264-9A4E-28931C17A913Q30821185-D2B65FF3-A4A9-4EEA-8A79-5B69F839244BQ30867699-D7B779DA-E8C6-4A51-A4E7-1FD95128B7C7Q33678047-37F90791-5771-444D-852E-7E024A60A7A4Q33864553-54986C54-0D41-4654-825D-1485898B162EQ33958541-9ED1F504-A41A-41DA-BE96-5D2DEF150BE9Q34299078-F3228854-6F79-4893-9EDE-E50BDBC6B9CFQ35142564-1DAA2241-B9F7-44C6-AE7D-FCA7606E993DQ35521094-42C69626-437B-47F4-9EDB-1E353719CADDQ36292086-DACE7324-98CD-4B3C-A59B-D4A0A7918288Q36402677-EA2AED0F-192D-494A-A5E8-7CDB399DF888Q36778732-DF972433-BDE1-48DB-99F1-46E76AC8F0CAQ37335755-CD9AD560-82C0-4715-9559-0D21FF6B7C05Q37350076-E6747DBF-E159-4118-83F6-EDDBDBCFD53BQ37693152-214982E0-2FC2-4D6E-848F-4D37677F4706Q38071558-B07C2E6F-3E5A-4C35-9F87-EDF585F9693DQ38627882-859D844B-B0CF-44A9-9B9D-AD021DB1DC94Q39381330-4296F3BC-7692-449B-BC17-77E6E92FF040Q41937695-38B1C594-D7A2-4BE0-887F-A418698E1E06
P2860
Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Intramuscular bioavailability ...... children with severe malaria.
@ast
Intramuscular bioavailability ...... children with severe malaria.
@en
Intramuscular bioavailability ...... children with severe malaria.
@nl
type
label
Intramuscular bioavailability ...... children with severe malaria.
@ast
Intramuscular bioavailability ...... children with severe malaria.
@en
Intramuscular bioavailability ...... children with severe malaria.
@nl
prefLabel
Intramuscular bioavailability ...... children with severe malaria.
@ast
Intramuscular bioavailability ...... children with severe malaria.
@en
Intramuscular bioavailability ...... children with severe malaria.
@nl
P2093
P2860
P50
P921
P1476
Intramuscular bioavailability ...... children with severe malaria.
@en
P2093
Arnaud Dzeing
Claire Nealon
Daniel Parzy
Timothy Planche
Ulrich Müller-Römer
Veronique Sinou
P2860
P304
P356
10.1128/AAC.46.12.3933-3939.2002
P407
P577
2002-12-01T00:00:00Z